Together, we can beat this.

Testing, Testing, Testing

Will save lives and get us all back to work

As the current war against the COVID-19 pandemic ensues, Prelude is eager to assist our fellow clinical researchers on the front lines. In this time of chaos, both our software and our certified data managers are ready and willing to support any clinical study seeking a cure for the coronavirus. For this reason, we are offering deeply discounted pricing for both software and labor for any COVID study, as well as the free use of our VISION ePro mobile application to enable direct patient data entry.
“Prelude prides itself on building complex studies with extreme efficiency, speeding cures and treatments to market as fast as possible.” – Richard Tieken CEO of Prelude Dynamics

One Week Database Builds


Our team of certified data managers are primed and ready to help you with the launch of VISION™ studies. By focusing and working together, with one heart, we can accomplish this in a matter of a week. Mid-study updates to accommodate protocol modifications can be made quickly. We all need to be ready to adapt.


VISION enables remote patient data entry to facilitate collecting clinical data while adhering to “social distancing” guidelines. Facilitate direct communication from patients by through built-in notifications as data is filled out. Send auto-reminders to patients to save investigators time with follow ups

Capitalize on Remote Monitoring and Powerful Edit Checks


We can’t be everywhere we want to be. Use our exemplary remote monitoring and data management capabilities to track and clean data as it is entered. Virtual sites promote adoption of decentralized trial conduct. Right now it’s critical to get to submission rapidly with unquestionable data.

Move From Phase 1 to Phase 2 and Beyond with Ease


As your trial progresses, re-use the work you’ve already done in your next Phase. We can help you move your forms from one study to the next and can even migrate baseline or historical data to ease the transition.

Let’s work together to conquer this virus and leave these challenging times in the taillights. While we’re sure the future of clinical trials will change based on this experience, we’re ready to adapt to those changes and support you and your clinical trials as we move to a “new normal”.